Moreover, MIR22HG suppresses the proliferation and metastasis of cancer cells also through MIR22HG-derived miR-22-3p targeting high mobility group box 1 (HMGB1) and binding to human gene antigen R (HuR) [80]. The gene discussed is HMGB1; the disease is cancer.